Daniel Lynch's Net Worth

Daniel Lynch's net worth is estimated to be at least $8,814,679.91 as of 05/26/2024. CoreStreet's estimation of Daniel Lynch's net worth is based on their sale of stock and current holding of stock.

Daniel Lynch is Director at Blueprint Medicines Corp. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,500 units of BPMC stock on 02/14/2018. Their biggest sale was on 06/28/2017 when they sold 32,500 units of Blueprint Medicines Corp stock for $1,634,100.00. They typically trade 5 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $8,814,679.91
Most recent insider trade:
  • Feb. 14, 2018

Daniel Lynch's Insider Trading History

Blueprint Medicines CorpTitleAmountPriceTypeTotal Value
Feb. 14, 2018
Director12,500$80.42Sell$1,005,250.00
Feb. 12, 2018
Director17,500$74.84Sell$1,309,700.00
Nov. 15, 2017
Director5,000$63.38Sell$316,900.00
Sept. 18, 2017
Director2,500$60.00Sell$150,000.00
July 5, 2017
Director7,500$55.06Sell$412,950.00
June 28, 2017
Director32,500$50.28Sell$1,634,100.00
Dec. 1, 2016
Director200$30.02Sell$6,004.00
Oct. 13, 2016
Director21,800$30.02Sell$654,436.00
Bluebird bio IncTitleAmountPriceTypeTotal Value
Aug. 31, 2017
Director500$120.00Sell$60,000.00
June 23, 2017
Director4,000$109.09Sell$436,360.00
June 20, 2017
Director2,500$120.03Sell$300,075.00
June 6, 2017
Director2,263$100.14Sell$226,616.82
May 25, 2017
Director2,000$80.00Sell$160,000.00
April 27, 2017
Director1,000$90.01Sell$90,010.00
April 25, 2017
Director2,000$86.75Sell$173,500.00
March 27, 2017
Director3,000$88.12Sell$264,360.00
March 16, 2017
Director237$100.07Sell$23,716.59
Feb. 15, 2017
Director150$80.22Sell$12,033.00
Feb. 14, 2017
Director850$80.01Sell$68,008.50
Jan. 27, 2017
Director1,000$70.09Sell$70,090.00
Oct. 5, 2015
Director3,000$100.41Sell$301,230.00
Sept. 17, 2015
Director1,500$140.06Sell$210,090.00
Sept. 8, 2015
Director7,000$132.75Sell$929,250.00